EMA regular press briefing on COVID-19
Location: Virtual meeting
The European Medicines Agency (EMA) is holding a press briefing to provide an update on its most recent activities in the context of the COVID-19 pandemic.
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).
Virtual briefings for the media are currently organised on a regular basis. Your feedback on this pilot is welcome. As a complement to these regular technical briefings, EMA will still organise ad-hoc press conferences as necessary and appropriate.
The press briefing will be held in English. No translations will be provided.